Available Until 4/19/2026
View Cart

Buprenorphine: Next Steps and Best Practices

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACPE Activity Number: 0204-0000-23-092-H08-P
Release Date: 4/19/2023
Expiration Date: 4/19/2026
Activity Type: Knowledge-based 
CE Credits:  2.0 contact hour, (0.20 CEU)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

Removal of the X-waiver has opened new doors for the role of the pharmacist. This webinar will review the role of buprenorphine in opioid use disorder (OUD) and the anticipated changes to pharmacy practices at the state level. Content matter experts from Emergency Medicine, Ambulatory Care, and Inpatient Care will share their protocols, best practices, and experiences in using buprenorphine. 

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Target Audience

This activity was planned to meet the educational needs of pharmacists who care for patients with opioid use disorder across varied practice sites. 

After completing this activity, the learner should be able to… 

1. Describe how the removal of the X-waiver impacted the role of the pharmacist and provider status at the state level. 

2. Discuss best practices, protocols, and approaches to patient care that include buprenorphine as a modality of Opioid Use Disorder (OUD) treatment. 

3. Give examples of pharmacist roles in facilitating the use of buprenorphine in the treatment of OUD.   

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Tom Kraus, JD
Vice President
Office of Government Relations
ASHP  

Jenny Koehl, PharmD, BCPS
Emergency Medicine Clinical Specialist
Massachusetts General Hospital
Boston, MA

Nathan Smith, PharmD, BCPS
Clinical Pharmacist
Mayo Clinic
Rochester, MN  

Adam J. Gordon, MD, MPH, FACP, DFASAM
Chief, Addiction Medicine
National Director, Medication Addiction Treatment in the VA (MAT-VA) Initiative
National co-Director, Coordinating Center of the Advanced Interdisciplinary Fellowship in Addiction Treatment
Director (emeritus), Vulnerable Veteran Innovative Patient Aligned Care Team (VIP) Initiative
Salt Lake City VA Health Care System
Salt Lake City, UT 

Moderator

Christi Jen, PharmD, BCPS
Clinical Pharmacy Manager
Mayo Clinic Arizona
Phoenix, AZ 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.